{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Meningococcal Disease Vaccines - Who's at Risk and the Future
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Purpose of Activity
To provide information on meningococcal disease and meningococcal vaccines.Learning Objectives
After completing this continuing education activity you will be able to:
- Outline issues related to meningococcal disease.
- Compare the clinical applications of conjugate and serogroup B (MenB) meningococcal vaccines.
Disclosures
The author and planners have disclosed no potential conflicts of interest, financial or otherwise.
Price:
$17.95
Credits:
- ANCC 1.5 CH / 1.0 APH
- DC - BON 1.5 CH
- KY-BON 1.5 CH
- GA - BON 1.5 CH
Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.
Awarded Advanced Pharmacology Hours
Awarded Advanced Pharmacology Hours
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: CNS0118
Published: Jan/Feb 2018
Expires: 12/31/2026
Required Passing Score: 14/19 (73%)
Specialties:
Infectious Diseases